nelarabine
novartis
['nelarabine', 'elara']
congress| #ash22 david o connor, delivers results on the genetic and clinical landscape amongst a large cohort of pts with t- all induction failure. poor prognostic outcomes remain amongst this patient subgroup, with a high enrichment of non-coding tal1 enhancer mutations seen 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm